Weekly Newsletter   Challenge account


Archive for July 23rd, 2016

Posted by TwillyD July 23, 2016

Relypsa Just Made a Move That Could Give AstraZeneca Pause

Last month we told you about Relypsa (NASDAQ: RLYP) a biopharmaceutical company that was enjoying being the sole provider of a drug used to treat hyperkalemia, a condition that causes life-threatening levels of potassium in a person’s blood. At the time we first reported Relypsa, we noted that the company’s stock was up and had Continue reading →